Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

DSpace/Manakin Repository

Files in this item

This item appears in the following Collection(s)